Wed, Apr 24, 2024
Volume 9, Issue 1 (6-2022)
vacres 2022, 9(1): 39-47 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Akele R, Enitan S, Adejumo E, Ezigbo E, Durosinmi A, Itodo G, et al et al . Acceptance of COVID-19 Vaccination at Different Hypothetical Efficacy and Safety Levels in Nigeria: A Cross-Sectional Web-based Survey. vacres 2022; 9 (1) :39-47
URL: http://vacres.pasteur.ac.ir/article-1-299-en.html
URL: http://vacres.pasteur.ac.ir/article-1-299-en.html
Richard Akele 
, Seyi Enitan * , Esther Adejumo , Eyiuche Ezigbo , Abiodun Durosinmi , Grace Itodo , Adedeji Abdulsalam , Michael Dada , Okeoghene Edafetanure-Ibeh , Oyekan Oyedoyin , Polit Yelpoji , Abah Idoko , Ogunwola Opeyemi , Ogbuji Nmesomachi , Edwin Okafor , Adesola Oyekale
, Seyi Enitan * , Esther Adejumo , Eyiuche Ezigbo , Abiodun Durosinmi , Grace Itodo , Adedeji Abdulsalam , Michael Dada , Okeoghene Edafetanure-Ibeh , Oyekan Oyedoyin , Polit Yelpoji , Abah Idoko , Ogunwola Opeyemi , Ogbuji Nmesomachi , Edwin Okafor , Adesola Oyekale
Department of Medical Laboratory Science, School of Public and Allied Health, Babcock University, Ilishan-Remo, Nigeria.
Abstract: (1344 Views)
Introduction: Vaccine hesitancy is a global phenomenon and vaccination efforts against the Coronavirus Disease 2019 (COVID-19) pandemic may be hampered by it. This study assessed the acceptance rate of COVID-19 vaccination at different hypothetical efficacy and safety levels in Nigeria. Methods: This web-based study was conducted among a selected Nigerian population between the month of February and May 2021 using an online self-administered structured questionnaire hosted by Survey Monkey. WhatsApp, Twitter and Facebook were used to disseminate the invitation to take the poll. Results: The finding of this study revealed that a larger proportion of the participants were males (53.9%), within the age group of 31-40 years (25.6%) and earn an average income of less than $500 per month. Individuals between the ages of 21 and 30 years and 31 to 40 years showed the highest levels of acceptability for the COVID-19 vaccine at 95% efficacy and 5% adverse effects. The older age group (>51 years and above) had the least vaccine acceptance rate (3.3%) at 75% vaccine efficacy and 20% side effect. Respondents who held the belief that vaccinations are essential for their health had a higher chance to accept the COVID-19 vaccine with OR: 0.76; 50%CI (0.00-0.00), OR: 95%CI (0.000-0.000), OR: 1.23; 95%CI (0.193-7.860) and OR: 0.696; 95%CI (0.048-10.047) based on religion, the occurrence of diabetes, pulmonary disease, and Hypertension, respectively. Conclusion: The results of this research indicate that vaccine acceptance rates are negatively correlated with participants' ages.
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.